BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 7907952)

  • 1. Taxol and taxotere in bladder cancer: in vitro activity and urine stability.
    Rangel C; Niell H; Miller A; Cox C
    Cancer Chemother Pharmacol; 1994; 33(6):460-4. PubMed ID: 7907952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative in vitro cytotoxicity of taxol and Taxotere against cisplatin-sensitive and -resistant human ovarian carcinoma cell lines.
    Kelland LR; Abel G
    Cancer Chemother Pharmacol; 1992; 30(6):444-50. PubMed ID: 1356649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Taxotere and taxol on in vitro colony formation of freshly explanted human tumor cells.
    Hanauske AR; Degen D; Hilsenbeck SG; Bissery MC; Von Hoff DD
    Anticancer Drugs; 1992 Apr; 3(2):121-4. PubMed ID: 1356030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro cytotoxic activity of Taxol and Taxotere on primary cultures and established cell lines of human ovarian cancer.
    Silvestrini R; Zaffaroni N; Orlandi L; Oriana S
    Stem Cells; 1993 Nov; 11(6):528-35. PubMed ID: 7906583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of endothelial cell function in vitro and angiogenesis in vivo by docetaxel (Taxotere): association with impaired repositioning of the microtubule organizing center.
    Hotchkiss KA; Ashton AW; Mahmood R; Russell RG; Sparano JA; Schwartz EL
    Mol Cancer Ther; 2002 Nov; 1(13):1191-200. PubMed ID: 12479700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of antitumour effects of docetaxel (Taxotere) on human gastric cancers in vitro and in vivo.
    Tanaka M; Obata T; Sasaki T
    Eur J Cancer; 1996 Feb; 32A(2):226-30. PubMed ID: 8664032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro antiproliferative activity of docetaxel (Taxotere), paclitaxel (Taxol) and cisplatin against human tumour and normal bone marrow cells.
    Braakhuis BJ; Hill BT; Dietel M; Kelland LR; Aapro MS; Zoli W; Lelieveld P
    Anticancer Res; 1994; 14(1A):205-8. PubMed ID: 7909419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative studies of taxol and taxotere on tumor growth and lymphocyte functions.
    Munkarah A; Chuang L; Lotzová E; Cook K; Morris M; Wharton JT
    Gynecol Oncol; 1994 Nov; 55(2):211-6. PubMed ID: 7959286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 'Rings' of F-actin form around the nucleus in cultured human MCF7 adenocarcinoma cells upon exposure to both taxol and taxotere.
    Rosenblum MD; Shivers RR
    Comp Biochem Physiol C Toxicol Pharmacol; 2000 Jan; 125(1):121-31. PubMed ID: 11790336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of taxol and Taxotere on two different human carcinoma cell lines.
    Garcia P; Braguer D; Carles G; el Khyari S; Barra Y; de Ines C; Barasoain I; Briand C
    Cancer Chemother Pharmacol; 1994; 34(4):335-43. PubMed ID: 7913421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of ionizing radiation with paclitaxel (Taxol) and docetaxel (Taxotere) in HeLa and SQ20B cells.
    Hennequin C; Giocanti N; Favaudon V
    Cancer Res; 1996 Apr; 56(8):1842-50. PubMed ID: 8620502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical activity of taxotere (RP 56976, NSC 628503) against freshly explanted clonogenic human tumour cells: comparison with taxol and conventional antineoplastic agents.
    Vogel M; Hilsenbeck SG; Depenbrock H; Danhauser-Riedl S; Block T; Nekarda H; Fellbaum C; Aapro MS; Bissery MC; Rastetter J
    Eur J Cancer; 1993; 29A(14):2009-14. PubMed ID: 7904173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective drug resistant human osteosarcoma cell lines.
    Burns BS; Edin ML; Lester GE; Tuttle HG; Wall ME; Wani MC; Bos GD
    Clin Orthop Relat Res; 2001 Feb; (383):259-67. PubMed ID: 11210963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor activity of taxotere (RP 56976, NSC 628503), a new taxol analog, in experimental ovarian cancer.
    Boven E; Venema-Gaberscek E; Erkelens CA; Bissery MC; Pinedo HM
    Ann Oncol; 1993 Apr; 4(4):321-4. PubMed ID: 8100146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paclitaxel (Taxol) and docetaxel (Taxotere): not simply two of a kind.
    Verweij J; Clavel M; Chevalier B
    Ann Oncol; 1994 Jul; 5(6):495-505. PubMed ID: 7918121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Taxotere: from yew's needles to clinical practice].
    Lavelle F; Gueritte-Voegelein F; Guenard D
    Bull Cancer; 1993 Apr; 80(4):326-38. PubMed ID: 7909695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Taxotere inhibits in-vitro growth of human colonic cancer cell lines.
    Karantanis E; Nicholson S; Morris DL
    Eur J Surg Oncol; 1994 Dec; 20(6):653-7. PubMed ID: 7995417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The taxoids: paclitaxel (Taxol) and docetaxel (Taxotere).
    Pazdur R; Kudelka AP; Kavanagh JJ; Cohen PR; Raber MN
    Cancer Treat Rev; 1993 Oct; 19(4):351-86. PubMed ID: 8106152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of taxol and taxotere in comparison with doxorubicin and cisplatin on primary cell cultures of human breast cancers.
    Zoli W; Flamigni A; Frassineti GL; Bajorko P; De Paola F; Milandri C; Amadori D; Gasperi-Campani A
    Breast Cancer Res Treat; 1995 Apr; 34(1):63-9. PubMed ID: 7749161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid high-performance liquid chromatographic determination of docetaxel (Taxotere) in plasma using liquid-liquid extraction.
    Ciccolini J; Catalin J; Blachon MF; Durand A
    J Chromatogr B Biomed Sci Appl; 2001 Aug; 759(2):299-306. PubMed ID: 11499483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.